drugset / Trial / NCT06415500

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

NCT06415500

Phase 1 Not yet recruiting 9 enrolled Anhui Provincial Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of NK042 for treatment of malignant ascites.

Timeline

Start
2024-05-06
Primary completion
2025-12-06
Completion
2026-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject NK042 Cell therapy Other